A coordinated strategy to scale-up advanced therapies for patient in Manchester
Lead Participant:
THE CHRISTIE NHS FOUNDATION TRUST
Abstract
Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.
Lead Participant | Project Cost | Grant Offer |
---|---|---|
THE CHRISTIE NHS FOUNDATION TRUST | £252,199 | £ 252,199 |
  | ||
Participant |
||
ASYMPTOTE LIMITED | ||
INSTIL BIO (UK) LIMITED | £713,963 | £ 499,773 |
MANCHESTER UNIVERSITY NHS FOUNDATION TRUST | £270,594 | £ 270,594 |
ASTRAZENECA UK LIMITED | ||
ASTRAZENECA PLC | ||
SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST | ||
APTUS CLINICAL LIMITED | £179,161 | £ 125,413 |
GLOBAL LIFE SCIENCES SOLUTIONS OPERATIONS UK LTD | £52,514 | £ 26,257 |
AGENUS UK LIMITED | ||
THE CHRISTIE NHS FOUNDATION TRUST | ||
THE CHRISTIE PATHOLOGY PARTNERSHIP LLP | £41,339 | £ 24,803 |
THE UNIVERSITY OF MANCHESTER | ||
CHAUCER GROUP LIMITED | ||
INNOVATE UK | ||
THE UNIVERSITY OF MANCHESTER | £560,476 | £ 560,476 |
FORMEDIX LIMITED | ||
DATATRIAL LIMITED |
People |
ORCID iD |
Victoria Sheard (Project Manager) |